On October 14, 2021 4SC AG (4SC, FSE Prime Standard: VSC) reported that it will attend and present at the European Organisation for Research and Treatment of Cancer Conference (EORTC) Cutaneous Lymphoma Group 20-21 Meeting in Marseille, France, from 14-16 Oct 2021 (Press release, 4SC, OCT 14, 2021, View Source [SID1234591244]). The posters will be available on 4SC’s website after the conference.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A summary of the posters is listed below.

Poster – RESMAIN study update: RESMAIN study – Evaluating resminostat for maintenance treatment of patients with advanced stage (Stage IIB‑IVB) mycosis fungoides (MF) or Sézarysyndrome (SS)
Poster – Scientific data from research exploring the mode-of-action of resminostat: Mode-of-action of HDAC inhibitor resminostat in CTCL cells